Alyson Krause, is on the Executive Board of MobileODT. Alyson also serves on the Board of Intellectual Capital and on the Board as Vice President of the Cienfuegos Foundation. She currently splits her time between working as a crisis turnaround consultant for distressed companies and providing strategic guidance for technology start-ups. Alyson also has experience in helping funds identify early to mid stage technology start-up investment opportunities. She started her career working in Management Consulting for an international software company, followed by working at The Federal Reserve Bank of New York, and SAIC.
Jonah is a Family Medicine physician and social entrepreneur. He completed his residency in Family Medicine and Community Health at the University of Pennsylvania and currently works as a family doctor in Philadelphia. He has created and/or collaborated on dozens of social innovations and startups that improve the delivery of medical care to underserved communities. He is particularly enthusiastic about building multidisciplinary public-private partnerships to advance primary care and social justice. He has deep expertise in new models of technology and relationship based care delivery that address access gaps and improve care quality both in the US and abroad.
Dan Caligor is the founder of the Business Advisory Network. Dan is MobileODT’s business and operations advisor, and serves on the board. Dan has divided the last 25 years between management consulting (Booz-Allen & Hamilton’s strategy practice, BearingPoint) and early-stage companies. He co-founded and was the COO of EyeIC, using novel algorithms for ophthalmology. He has advised, joined or led the founding teams of numerous start-ups in multiple industries, including wireless data, medical devices, pro audio and personal productivity. Dan holds an MBA from Columbia Business School.
Jonathan J. Fleming is President and Treasurer of NEHI, a national health care policy think tank. Founded in 2002, NEHI is a nonprofit, non-partisan, evidence-based institute dedicated to identifying innovations that provide solutions to the most pressing issues facing our health care system today. Since 1999, Mr. Fleming has been the Managing Partner of Oxford Bioscience Partners, an international venture capital firm specializing in life science investments, based in Boston, Massachusetts.
Mr. Fleming has been in the investment business for more than 29 years, starting and financing growth companies in the United States, Europe, Israel and Asia. Prior to joining Oxford Bioscience Partners in 1996, he was a Founding General Partner of MVP Ventures in Boston, MA. He began his investment career with TVM Techno Venture Management in Munich, Germany. Mr. Fleming also co-founded Medica Venture Partners, a venture capital investment firm specializing in early stage health care and biotechnology companies in Israel, and the Korea Seoul Life Science Fund, based in Seoul, Korea. Mr. Fleming is a director of Xencor (NASDAQ: XNCR) and several private early stage life science companies. He is also a director of Leerink Partners, a Boston based investment bank specializing in health care companies.
In addition, Mr. Fleming has been a Senior Lecturer at the MIT Sloan School of Management since 2003, where he co-teaches a class on business strategy for life science managers. He is an advisor to the SBIR program of the National Cancer Institute. Mr. Fleming holds a Master's degree in Public Administration from Princeton University’s Woodrow Wilson School of Public and International Affairs.
Prof. Robert Lenkinski is the Charles A. and Elizabeth Ann Sanders Chair in Translational Research; Jan and Bob Pickens Distinguished Professorship in Medical Science, in Memory of Jerry Knight Rymer and Annette Brannon Rymer and Mr. and Mrs. W.L. Picken, at UT Southwestern, Dallas, Texas
Previously, he was a Professor of Radiology at Harvard Medical School, a Vice-Chairman and Director of Radiology Research at Beth Israel Deaconess Medical Center, and Co-Director, Longwood Small Animal Imaging Facility. One of his major research interests is the clinical applications of in vivo Magnetic Resonance spectroscopy. Dr Lenkinski is also developing in vivo multinuclear MR imaging methods. A more recent area of interest has been molecular imaging. He received his Ph.D in Chemistry from the University of Houston. He has authored many articles in peer-reviewed journals and has been awarded several patents.
Doron J.D. Rosen has more then 25 years of experience in the medical field including more then 12 years as an entrepreneur and investor in medical devices and biotech.
Since 1996 Dr. Rosen has been actively involved in healthcare investments both as active investor and adviser to start-up companies, investment groups and incubators through Romed Ltd. He also works as an Obstetrician Gynecologist at the Meir Medical Center in Israel and lectures at the Tel Aviv University School of Medicine.
Dr. Rosen has founded and served as executive vice president (business development, funding, coordination of clinical trials and regulatory activities) from 1999-2005 of Advanced Medical Diagnostics, SA (formerly MD medical Diagnostics Inc.), a company that developed and markets HistoScanning – a tool for non invasive tissue characterization for clinically meaningful visualization of cancer within healthy tissues, including the Ovary, Breast and Prostate.
Dr. Rosen holds MD degree from the Hadassah medical School, Jerusalem, as well as MBA in health administration summa cum laude from the Recanati Faculty of Management, Tel Aviv University. He has recently completed the Directors and Senior Officers course at LAHAV, Tel Aviv University. He is a member of numerous international medical associations and has authored over 50 scientific papers.
Aric has a degree in Biology with a strong drive for marketing life saving treatments and relationship building. Aric has worked with companies' in many areas such as in helping companies' assess investment opportunities, business development ventures, creating partnerships and community outreach efforts. Aric is charismatic, venturesome and self-assured while dealing with people on a personal level and communicating with high level executives. Aric will bring his knowledge of biology and human anatomy along with strong business acumen in his efforts to help MobileODT.
Chloé Pinto, M.Sc. is MobileOCT’s Ambassador and Public Health researcher. Chloe has a dual bachelor’s degree in fine arts and child development from Tufts University and the School of the Museum of Fine Arts Boston as well as an M.Sc. in Neuroscience from King’s College London, conducting her master’s thesis in developmental biology at the Weizmann Institute of Science in Rehovot, Israel. Having lived and worked in the realm of health around the world, Chloé’s interest lies in international health, specifically finding creative, durable and culturally sensitive solutions to help underserved communities across the globe.
Alyson Krause: founding member of Claro International Solutions (CIS), a technology investment consulting company with offices in Cambridge, Massachusetts and Panama City, Panama. CIS has domain expertise in increasing value for intellectual property and helping businesses grow world wide. CIS focuses on assisting international equity sources in identifying business opportunities in the technology, clean energy, life science and medical device areas. CIS also provides international business development services to the technology and infrastructure sectors.
Dr. Jonah Mink is a resident physician at the University of Pennsylvania and an experienced social entrepreneur. Through his work with the Millennium Villages Project, City Health Works!, in India and in Israel, he has created and collaborated on innovations that improve the delivery of medical care to marginalized communities. He co-founded the social venture Migrant Health which focuses on building financially sustainable and socially responsible models to incorporate marginalized communities into mainstream healthcare systems.